More precisely, in early clinical trials, Retatrutide has shown the potential for significant weight loss, with participants on the highest dose losing an average of 28.7% of their body weight over 68 weeks, which is double the weight loss seen with other GLP-1 medications like Ozempic and Wegovy
J Biol Chem 276 : 1839918406, 2001
While both medications serve the same primary purpose, important differences in dosage, duration, and impact on weight may make one more suitable for your specific needs
A single pack contains 30 tablets
- Phase 2: Focuses on the drug's effectiveness and further evaluates its safety in a larger group of individuals with the targeted condition
When you work closely with a healthcare professional, you can receive personalized guidance on how to use semaglutide GLP-1 effectively to target belly fat and achieve specific weight loss goals